NeuroMetrix gets clearance to market an over-the-counter pain management device

Photo taken from the company’s website.

A woman gardens while wearing a NeuroMetrix pain-management device on her leg.

Waltham medical device maker NeuroMetrix Inc. said Tuesday that its wearable technology for treatment of chronic pain has received a clearance from the Food and Drug Administration for over-the-counter use.

The device is based on wearable technology that utilizes comfortable, non-invasive electrical stimulation of sensory nerves to induce safe and effective pain relief, the company said in a press release. The technology is presently deployed in the company’s Sensus Pain Management System.

In a statement, NeuroMetrix president and chief executive Shai N. Gozani said: “Patient response to Sensus, our prescription wearable device for treatment of chronic pain, has been very positive since it was launched in early 2013. We believe that there is a substantial consumer market for an over-the-counter version of this technology. The ability to offer both prescription and over-the-counter products will give us maximal market exposure and allow us to reach more people with chronic pain. We anticipate a commercial launch in 2015.”

Chris Reidy can be reached at
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of